Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

unding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Annual Report on Form 10-K for the year ended December 31, 2006 and the Company's Form 10-Q for the quarter ended June 30, 2007. In particular, there can be no assurance as to the results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Sonic Foundry completes $11.25M stock offer
4. Orion Energy completes $5M capital round
5. RedPrairie completes MARC acquisition
6. Metavante completes purchase of check processing firm
7. GE completes $1.2 billion acquisition
8. M & Is Metavante completes Brasfield Corp. acquisition
9. Metavante completes GHR Systems acquisition
10. Metavante completes TREEV acquisition
11. Johnson Controls completes sale of French unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Researchers at Johns Hopkins have mapped the sound-processing part ... both the proverbial forest and the trees in view. ... views of brain activity within mice, and it enabled ... mice "called" to each other. The results, which represent ... process language, appear online July 31 the journal ...
(Date:7/31/2014)... 31, 2014 According to a ... Dots Market - Global Industry Analysis, Size, Share, Growth, ... valued at USD 88.5 million in 2011, which is ... at a CAGR of 53.8% from 2013 to 2023. ... at  http://www.transparencymarketresearch.com/quantum-dots.html Increasing demand for energy ...
(Date:7/31/2014)... North Shore Towers, a luxury co-op community based just ... of the nation’s leading combined heating and power (CHP) systems ... CHP system. The original CHP system had been maintained since ... life of the plant, GI Energy was contracted to replace ... equipment, while maintaining continuous operation of the entire complex. ...
(Date:7/31/2014)... CollabRx, Inc. (NASDAQ: CLRX), a leading provider ... today announced that it will hold an investor conference ... financial results for the first quarter of fiscal 2015 ... the current fiscal year. , The dial-in number for ... 2014, at 5 p.m. EDT (2 p.m. PDT) is ...
Breaking Biology Technology:New mapping approach lets scientists zoom in and out as the brain processes sound 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 3Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 4North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2
... Informex , the leading meeting place for buyers ... the Global Pharma Sourcing Conference to be held December ... Philadelphia, Pennsylvania. The two day program will be jointly ... address key issues that global chemical and pharmaceutical industry ...
... Corp. (IDC), a privately held biotechnology company developing ... and allergy, announced today that it has entered ... investigate the use of IDC,s Glucopyranosyl Lipid Adjuvant ... in the field of allergy. (Logo: ...
... Inc. (Nasdaq: SGMO ) today reported third quarter ... third quarter ended September 30, 2011, Sangamo reported a consolidated ... to a net loss of $8.7 million, or $0.19 per ... 30, 2011, the Company had cash, cash equivalents and marketable ...
Cached Biology Technology:Informex Introduces a Thorough Global Pharma Perspectives Conference 2Sangamo BioSciences Reports Third Quarter 2011 Financial Results 2Sangamo BioSciences Reports Third Quarter 2011 Financial Results 3Sangamo BioSciences Reports Third Quarter 2011 Financial Results 4Sangamo BioSciences Reports Third Quarter 2011 Financial Results 5Sangamo BioSciences Reports Third Quarter 2011 Financial Results 6
(Date:7/31/2014)... National Science Foundation (NSF), counters a widely-held scientific ... indicating instead that certain Arctic lakes store more ... , The study, published this week in ... lakes, which occur as permafrost thaws and creates ... converting what was previously frozen land into lakes. ...
(Date:7/31/2014)... have identified a gene mutation that may allow the carrier ... per night. The genetic variant also appears to provide ... show that a participant with p.Tyr362His a variant of ... of only five hours, which was more than one hour ... hours and five minutes per night. The twin with ...
(Date:7/31/2014)... Spain, France, and the U.S. has discovered and ... definitive member of the tribe Omaliini that has ... description were made possible through the use of ... allows the detailed study of otherwise invisible specimens ... in the journal Annals of the Entomological ...
Breaking Biology News(10 mins):Certain Arctic lakes store more greenhouse gases than they release 2Study of twins discovers gene mutation linked to short sleep duration 2
... announce BIOLOGY OPEN (BiO), a new online only, Open ... the biological sciences including cell science, developmental biology and ... publication for peer reviewed, scientifically sound observations and valid ... address some big issues in publishing and is supported ...
... parents can fill out in pediatrician waiting rooms may someday ... (ASD) , according to a study funded by the National ... Pediatrics , the study,s design also provides a model for ... to their practice. "Beyond this exciting proof of concept, ...
... on April 27, 2011, in the peer-reviewed open-access journal ... oceanographic and prey measurements can be used to identify beaked ... Hole, and the Naval Undersea Warfare Center listened for foraging ... off the east coast of Andross Island in the Bahamas. ...
Cached Biology News:Announcing BIOLOGY OPEN from the Company of Biologists 25-minute screen identifies subtle signs of autism in 1-year olds 2Identifying beaked whale foraging habitat in the tongue of the ocean, Bahamas 2
... Vivaclear centrifugal filters are disposable microfiltration devices for ... in the range 100 l to 500 l. ... accepting 2.2 ml centrifuge tubes. Product Features: ... size Low hold up volume ( ...
... fully automates pharmaceutical sample preparation tasks ... transfer, mixing and dilutions. Capabilities also ... The Prelude performs these functions in ... 11. The Prelude performs quantitative ...
... any standard fixed-angle microcentrifuge rotor at ... centrifuge tube filters consist of a ... tube. They filter by centrifugation for ... preparation, removal of cells from media ...
... Not treated (or medium binding) ... and binds biomolecules through passive interactions,• ... of large molecules, such as antibodies, ... can interact with the surface,• Binding ...
Biology Products: